Skip to main content

FDA Approvals

FDA Approvals, Payers' Guide
Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by the FDA for Patients with Familial Hypercholesterolemia
Loretta Fala
Read More
FDA Approvals, Payers' Guide
Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals, Payers' Guide
Tresiba (Insulin Degludec Injection) and Ryzodeg 70/30 (Insulin Degludec and Insulin Aspart Injection): Two New Insulin Analogs for Glycemic Control in Diabetes Mellitus
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals, Payers' Guide
Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals, Payers' Guide
Competition Heats Up in Rheumatoid Arthritis and Other Autoimmune Conditions
Gary Branning, MBA
Read More
FDA Approvals, Payers' Guide
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Phoebe Starr
Read More
FDA Approvals
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Phoebe Starr
Read More
FDA Approvals
Venetoclax Shows Strong Activity in CLL
Phoebe Starr
Read More
FDA Approvals, In the News
FDA Approves Integra Omnigraft Dermal Regeneration Matrix to Treat Diabetic Foot Ulcers
Read More
Page 38 of 53
Results 371 - 380 of 525